# SARS-CoV-2 Spike glycoprotein

## COVID-19 XBB.1.5 Novavax 0.5mL/dose (2.5mL/vial)

| TAH Drug Code      | [ICONVXBB](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ICONVXBB)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | For active immunization to prevent COVID-19 caused by SARS-CoV-2 virus in individuals 12 years of age and older.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Dosing             | Patients aged 12 years or older: - Not Previously Vaccinated with Any COVID-19 Vaccine: 0.5 mL IM for 2 doses administered 3 weeks apart. - Previously Vaccinated with Any COVID-19 Vaccine: 0.5 mL IM as a single dose at least 3 months after receipt of a previous dose of COVID-19 vaccine.                                                                                                                                                                                                                                                                                                                                           |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Contraindications  | History of severe allergic reaction to any component of the vaccine or those who experienced a severe allergic reaction after a previous dose of this vaccine.                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Adverse Effects    | Common: Erythema at injection site (0.7-7.5%)， Injection site pain， Swelling at injection site (0.8-8%)， Tenderness， Injection site， Nausea， Vomiting， Arthralgia (6.2-23.4%)， Myalgia (12.6-50.7%)， Headache (15.3-56.9%)， Fatigue， Fever (0.4-16.9%)， Malaise Serious: Congestive heart failure (0.004%)， Heart failure， Myocarditis (0.06%)， Pericarditis， Acute cholecystitis (0.02%)， Deep venous thrombosis (0.007%)， Portal vein thrombosis (0.004%)， Thrombosis (0.007%)， Thrombosis of mesenteric artery (0.004%)， Anaphylaxis， Hypersensitivity reaction (0.1%)， Pulmonary embolism (0.02%)， Angioedema |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| More Info          | [UpToDate](https://www.uptodate.com/contents/sars-cov-2-spike-glycoprotein-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |

## COVID-19 Vaccine Medigen 0.5mL/dose(10 dose/vial)

| TAH Drug Code      | [ICOVMVC](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ICOVMVC)                                                                                                                                      |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Medigen COVID-19 Vaccine is indicated for active immunization of individuals 20 years of age and older for the prevention of coronavirus disease 2019 (COVID-19).                                               |
| Dosing             | Age > or = 20 years old: IM: 0.5 mL per dose for 2 doses administered 28 days apart.                                                                                                                            |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                   |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                   |
| Contraindications  | History of a severe allergic reaction after a previous dose or to a component of the formulation; history of immediate allergic reaction to a previous dose; known allergy to any component of the formulation. |
| Adverse Effects    | erythema at injection site， pain at injection site， and swelling at injection site. asthenia， fatigue， fever， headache， myalgia， and nausea.                                                             |
| Pregnancy          | Unknown                                                                                                                                                                                                         |
| Lactation          | Unknown                                                                                                                                                                                                         |
| More Info          | [UpToDate](https://www.uptodate.com/contents/sars-cov-2-spike-glycoprotein-drug-information)                                                                                                                    |

## COVID-19 Vaccine Novavax 0.5mL/dose (5mL/vial)

| TAH Drug Code      | [ICOVNVV](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ICOVNVV)                                                                                                                                      |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | COVID-19 Vaccine is indicated for active immunization of individuals 18 years of age and older for the prevention of coronavirus disease 2019 (COVID-19).                                                       |
| Dosing             | IM， 0.5 mL， > or = 18 years 2 doses administered > or = 3 weeks apart.                                                                                                                                        |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                   |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                   |
| Contraindications  | History of a severe allergic reaction after a previous dose or to a component of the formulation; history of immediate allergic reaction to a previous dose; known allergy to any component of the formulation. |
| Adverse Effects    | erythema at injection site， pain at injection site， and swelling at injection site. asthenia， fatigue， fever， headache， myalgia， and nausea.                                                             |
| Pregnancy          | Unknown                                                                                                                                                                                                         |
| Lactation          | Unknown                                                                                                                                                                                                         |
| More Info          | [UpToDate](https://www.uptodate.com/contents/sars-cov-2-spike-glycoprotein-drug-information)                                                                                                                    |

## COVID-19 JN.1 Novavax 0.5mL/dose

| TAH Drug Code      | [INOVJN](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=INOVJN)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 12 years of age and older.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Dosing             | Individuals 12 Years of Age and Older Never Vaccinated with Any COVID-19 Vaccine: Administer a series of two doses (0.5 mL each) 3 weeks apart. Individuals 12 Years of Age and Older Vaccinated Only with One Dose of Any Novavax COVID-19 Vaccine， Adjuvanted: Administer a single 0.5 mL dose at least 3 weeks after the previous dose to complete the 2-dose series of Novavax COVID-19 Vaccine， Adjuvanted. Individuals 12 Years of Age and Older Vaccinated with Any COVID-19 Vaccine， Other than Novavax COVID-19 Vaccine， Adjuvanted， or with Two or More Doses of Novavax COVID-19 Vaccine， Adjuvanted: Administer a single 0.5 mL dose at least 2 months after receipt of the last previous dose of COVID-19 vaccine. Individuals 12 Years of Age and Older with Certain Kinds of Immunocompromise: For individuals with certain kinds of immunocompromise， an additional dose of Novavax COVID-19 Vaccine， Adjuvanted (2024 – 2025 Formula) may be administered at least 2 months following the last dose of a COVID-19 vaccine (2024 –2025 Formula). Additional doses of Novavax COVID-19 Vaccine， Adjuvanted (2024 – 2025 Formula) may be administered at the discretion of the healthcare provider， taking into consideration the individual’s clinical circumstances. The timing of the additional doses may be based on the individual’s clinical circumstances. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Contraindications  | History of a severe allergic reaction (e.g.， anaphylaxis) to any component of the Novavax COVID-19 Vaccine， Adjuvanted or following a previous dose of a Novavax COVID-19 Vaccine， Adjuvanted.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Adverse Effects    | Solicited adverse reactions included: Injection site pain/tenderness， fatigue/malaise， muscle pain， headache， joint pain， nausea/vomiting， injection site redness， injection site swelling， and fever.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| More Info          | [UpToDate](https://www.uptodate.com/contents/sars-cov-2-spike-glycoprotein-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |

